Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Australian Pharmaceutical Market Remains Heavily Reliant on Imported Drugs.


DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c44523) has announced the addition of Espicom Business Intelligence's: Australia Pharmaceutical Market Intelligence Report to their offering.

This in-depth report provides an invaluable mix of vital market data and background information, including five-year market projections. The report comprises four main sections:

1.) Pharmaceutical Market Outlook

2.) Background Data

3.) Healthcare System

4.) Accessing the Pharmaceutical Market.

Report sections are dynamically updated, being re-issued when market developments demand it.

Australia represents a highly advanced pharmaceutical market. The country has an advanced healthcare system and demand for all types of pharmaceuticals is high. Prices in Australia tend to be low for a developed country, principally due to tight public pricing and reimbursement regulations through the Pharmaceutical Benefits Scheme (PBS PBS
 in full Public Broadcasting Service

Private, nonprofit U.S. corporation of public television stations. PBS provides its member stations, which are supported by public funds and private contributions rather than by commercials, with educational, cultural,
). The PBS has come under attack from the multinational industry, and the US government has pressed for greater transparency as part of negotiations for the Free Trade Agreement which took effect in 2005. The Australian government has, however, consistently affirmed that alterations to the PBS have not been part of any deal.

Australia has a small but growing domestic industry, augmented by the presence of many multinational producers. The market remains heavily reliant on imported drugs, however; local R&D has yet to reach significant proportions, despite continuing government incentives. The majority of pharmaceutical imports are sourced from the European Union European Union (EU), name given since the ratification (Nov., 1993) of the Treaty of European Union, or Maastricht Treaty, to the

European Community
. Low prices for branded products mean that generics are not yet widely used.

Domestic Producers include the following:

- Alphapharm

- AMRAD AMRAD Associação Portuguesa de Amadores de Rádio (Portugese)
AMRAD American Radio and Research Corporation (very early US radio broadcasting company)
AMRAD ARPA Measurements Radar
 Corporation

- AstraZeneca Pharmaceuticals Pty Ltd PTY LTD Propriety Limited (company structure in Australia) .

- Commonwealth Serum Laboratories (CSL (Computerese as a Second Language) Said of people who love to speak high-tech words even though they often use them erroneously. See TLA.

1. CSL - Computer Structure Language. A computer hardware description language, written in BCPL.
)

- Eli Lilly Eli Lilly can refer to:
  • Eli Lilly and Company, a global pharmaceutical company
  • Colonel Eli Lilly (1839-1898), founder of Eli Lilly and Company
  • Eli Lilly (industrialist) (1885-1977), former president of Eli Lilly and Company
 Australia Pty Ltd.

- GlaxoSmithKline Australia

- Hamilton Pharmaceutical Pty Ltd. (Hamilton Laboratories)

- Mayne Group

- Pan Pharmaceuticals (now Sphere Healthcare)

- Sigma Pharmaceuticals Pty Ltd

- Stiefel Laboratories Pty Ltd

For more information visit http://www.researchandmarkets.com/reports/c44523

Source: Espicom Business Intelligence Introduction
Espicom Business Intelligence is a publisher of independent and impartial information and analysis services focusing on the pharmaceutical and medical device markets.
 
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 6, 2006
Words:299
Previous Article:Hong Kong Medical Device Market Affected by Changes in the Healthcare Sector.
Next Article:Research and Markets: Doosan Solidly Outperformed Peers in 2005 but Cash Flow Issues May Weaken the Conglomerate.
Topics:



Related Articles
What the world, and its un, can do. (UNconventional: A Point of View).
Support for drug imports growing.
Reliant expands on Allen Road.
Reliant expands on Allen Road.
PILL MAKERS RUSHING TO PUSH RISKS OF BUYING DRUGS ABROAD.
Canadian drugs: panacea or problem?
Consumers, states challenge federal ban on drug imports.
The U.S.-Australia Free Trade Agreement.
CEO finds new home at another drug co.: Bradley Sheares to lead Reliant Pharmaceuticals.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles